A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population

ClinicalTrials.gov ID: NCT00959049

Public ClinicalTrials.gov record NCT00959049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Observer-blind, Multi-center, Noninferiority Comparison of the Immune Response of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Trivalent Inactivated Split-Virion Influenza Vaccine in a Pediatric Population Aged Greater Than or Equal to 6 Months to Less Than 18 Years.

Study identification

NCT ID: NCT00959049
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Seqirus; Industry
Enrollment: 1,474 participants

Conditions and interventions

Conditions

Influenza

Interventions

CSL's Influenza Virus Vaccine (Afluria) Biological
Influenza Virus Vaccine (Fluzone) Biological

Biological

Eligibility (public fields only)

Age range: 6 Months to 17 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2009
Primary completion: Nov 30, 2009
Completion: Apr 30, 2010
Last update posted: May 15, 2017

2009 – 2010

United States locations

U.S. sites: 23
U.S. states: 11
U.S. cities: 19

Facility	City	State	ZIP	Site status
Not listed	Chandler	Arizona	85224	—
Not listed	Harrisburg	Arkansas	72432	—
Not listed	Jonesboro	Arkansas	72401	—
Not listed	Little Rock	Arkansas	72205	—
Not listed	Mountain Home	Arkansas	72653	—
Not listed	Melbourne	Florida	32935	—
Not listed	Bardstown	Kentucky	40004	—
Not listed	Omaha	Nebraska	68134	—
Not listed	Binghamton	New York	13901	—
Not listed	Elmira	New York	14901	—
Cincinnati Children's Hospital Medical Center- Division of Infectious Disease	Cincinnati	Ohio	45229	—
Not listed	Warr Acres	Oklahoma	73132	—
UPMC / Community Medicine Inc	Greenville	Pennsylvania	16125	—
Pediatric Associates of Latrobe	Latrobe	Pennsylvania	15650	—
Pediatric Alliance Greentree Division	Pittsburgh	Pennsylvania	15220	—
South Hills Pediatrics	Pittsburgh	Pennsylvania	15227	—
Not listed	Pittsburgh	Pennsylvania	15241	—
Not listed	Salt Lake City	Utah	84109	—
Not listed	Salt Lake City	Utah	84121	—
Not listed	Salt Lake City	Utah	84124	—
Not listed	South Jordan	Utah	84095	—
Not listed	Burke	Virginia	22015	—
Not listed	Vienna	Virginia	22180	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00959049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 15, 2017 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00959049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →